U.S. Longevity & General Wellness Supplements Market Size, Share & Trends Analysis Report By Application (Longevity Supplements, General Wellness Supplements), And Segment Forecasts, Consumer Behavior And Competitive Analysis, 2026 - 2033
Description
U.S. Longevity & General Wellness Supplements Market Summary
The U.S. longevity & general wellness supplements market size was valued at USD 6.35 billion in 2025 and is anticipated to reach USD 10.13 billion by 2033, expanding at a CAGR of 6.06% from 2026 to 2033. This sustained growth is driven by rising consumer awareness around preventive health, aging populations seeking to extend health spans, and increased interest in personalized wellness solutions.
Evolving Consumer Demographics
The evolving demographic landscape in the U.S. is a major catalyst for the growing demand for longevity and general wellness supplements. According to U.S. Census data, as the Baby Boomer generation ages, the population of individuals 65 and older is projected to nearly double by 2060. This shift creates sustained demand for products supporting healthy aging, mobility, cognitive function, and chronic disease prevention.
Health and wellness are becoming increasingly important for the future, especially among the younger consumers, such as Millennials and Gen Z, who are the first to incorporate vitamins and other dietary supplements into their lives. Immunity, stress management, skin health, and even longevity support products are the focus of these youngsters. Such escalating cross-generation requests not only broaden the consumer pool but also facilitate the introduction of new, better, and more personalized formulations and delivery modes. As this trend prevails along with the old population, it is altering the playing field of the market and supplying the manufacturers who provide specific, scientifically proven wellness solutions for all ages with a steady growth opportunity.
U.S. Longevity & General Wellness Supplements Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. longevity & general wellness supplements market report on the basis of application:
The U.S. longevity & general wellness supplements market size was valued at USD 6.35 billion in 2025 and is anticipated to reach USD 10.13 billion by 2033, expanding at a CAGR of 6.06% from 2026 to 2033. This sustained growth is driven by rising consumer awareness around preventive health, aging populations seeking to extend health spans, and increased interest in personalized wellness solutions.
Evolving Consumer Demographics
The evolving demographic landscape in the U.S. is a major catalyst for the growing demand for longevity and general wellness supplements. According to U.S. Census data, as the Baby Boomer generation ages, the population of individuals 65 and older is projected to nearly double by 2060. This shift creates sustained demand for products supporting healthy aging, mobility, cognitive function, and chronic disease prevention.
Health and wellness are becoming increasingly important for the future, especially among the younger consumers, such as Millennials and Gen Z, who are the first to incorporate vitamins and other dietary supplements into their lives. Immunity, stress management, skin health, and even longevity support products are the focus of these youngsters. Such escalating cross-generation requests not only broaden the consumer pool but also facilitate the introduction of new, better, and more personalized formulations and delivery modes. As this trend prevails along with the old population, it is altering the playing field of the market and supplying the manufacturers who provide specific, scientifically proven wellness solutions for all ages with a steady growth opportunity.
U.S. Longevity & General Wellness Supplements Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. longevity & general wellness supplements market report on the basis of application:
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Longevity Supplements
- Type
- NMN
- NR
- NAD+
- NADH
- Resveratrol
- Fisetin
- Quercetin
- Cucurmin
- Collagen
- Pterostilbene
- Others
- Sales Channel
- Online
- Direct to consumer
- Other e-commerce channels
- Offline
- Hypermarkets/Supermarkets
- Pharmacies & Drug Stores
- Others
- General Wellness Supplements
- Type
- Vitamins
- Multivitamins
- Individual vitamins
- Minerals
- Amino acids
- Probiotics
- Collagen
- Fish oils
- Coenzyme Q10
- Herbal extracts
- Others
- Sales Channel
- Online
- Direct to consumer
- Other e-commerce channels
- Offline
- Hypermarkets/Supermarkets
- Pharmacies & Drug Stores
- Others
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Application Segment
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. U.S. Longevity & General Wellness Supplements Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTEL Analysis
- Chapter 4. U.S. Longevity & General Wellness Supplements Market: Application Business Analysis
- 4.1. Application Segment Dashboard
- 4.2. U.S. Longevity & General Wellness Supplements Market Application Movement Analysis
- 4.3. U.S. Longevity & General Wellness Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 4.4. Longevity Supplements
- 4.4.1. U.S. Longevity Supplements based Market, 2021 - 2033 (USD Million)
- 4.4.1.1. Longevity Supplements Type
- 4.4.1.1.1. Longevity Supplements Type based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.1. NMN
- 4.4.1.1.1.1.1. NMN based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.2. NR
- 4.4.1.1.1.2.1. NR based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.3. NAD+
- 4.4.1.1.1.3.1. NAD+ based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.4. NADH
- 4.4.1.1.1.4.1. NADH based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.5. Resveratrol
- 4.4.1.1.1.5.1. Resveratrol based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.6. Fisetin
- 4.4.1.1.1.6.1. Fisetin based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.7. Quercetin
- 4.4.1.1.1.7.1. Quercetin based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.8. Cucurmin
- 4.4.1.1.1.8.1. Cucurmin based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.9. Collagen
- 4.4.1.1.1.9.1. Collagen based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.10. Pterostilbene
- 4.4.1.1.1.10.1. Pterostilbene based Market, 2021 - 2033 (USD Million)
- 4.4.1.1.1.11. Others
- 4.4.1.1.1.11.1. Others based Market, 2021 - 2033 (USD Million)
- 4.4.1.2. Longevity Supplements Sales Channel
- 4.4.1.2.1. Longevity Supplements Sales Channel based Market, 2021 - 2033 (USD Million)
- 4.4.1.2.1.1. Online
- 4.4.1.2.1.1.1. Online Sales Channel based Market, 2021 - 2033 (USD Million)
- 4.4.1.2.1.1.2. Direct to consumer
- 4.4.1.2.1.1.2.1. Direct to consumer-based Market, 2021 - 2033 (USD Million)
- 4.4.1.2.1.1.3. Other e-commerce channels
- 4.4.1.2.1.1.3.1. Other e-commerce channels-based Market, 2021 - 2033 (USD Million)
- 4.4.1.2.1.2. Offline
- 4.4.1.2.1.2.1. Offline Sales Channel based Market, 2021 - 2033 (USD Million)
- 4.4.1.2.1.2.2. Hypermarkets/Supermarkets
- 4.4.1.2.1.2.2.1. Hypermarkets/Supermarkets-based Market, 2021 - 2033 (USD Million)
- 4.4.1.2.1.2.3. Pharmacies & Drug Stores
- 4.4.1.2.1.2.3.1. Pharmacies & Drug Stores-based Market, 2021 - 2033 (USD Million)
- 4.4.1.2.1.2.4. Others
- 4.4.1.2.1.2.4.1. Others based Market, 2021 - 2033 (USD Million)
- 4.5. General Wellness Supplements
- 4.5.1. U.S. General Wellness Supplements Market, 2021 - 2033 (USD Million)
- 4.5.1.1. General Wellness Supplements Type
- 4.5.1.1.1. General Wellness Supplements Type based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.1. Vitamins
- 4.5.1.1.1.1.1. Vitamins based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.1.2. Multivitamins
- 4.5.1.1.1.1.2.1. Multivitamins based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.1.3. Individual vitamins
- 4.5.1.1.1.1.3.1. Individual vitamins-based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.2. Minerals
- 4.5.1.1.1.2.1. Minerals based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.3. Amino acids
- 4.5.1.1.1.3.1. Amino acids-based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.4. Probiotics
- 4.5.1.1.1.4.1. Probiotics based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.5. Collagen
- 4.5.1.1.1.5.1. Collagen based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.6. Fish oils
- 4.5.1.1.1.6.1. Fish oils based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.7. Coenzyme Q10
- 4.5.1.1.1.7.1. Coenzyme Q10 based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.8. Herbal extracts
- 4.5.1.1.1.8.1. Herbal extracts based Market, 2021 - 2033 (USD Million)
- 4.5.1.1.1.9. Others
- 4.5.1.1.1.9.1. Others based Market, 2021 - 2033 (USD Million)
- 4.5.1.2. General Wellness Supplements Sales Channel
- 4.5.1.2.1. General Wellness Supplements Sales Channel based Market, 2021 - 2033 (USD Million)
- 4.5.1.2.1.1. Online
- 4.5.1.2.1.1.1. Online Sales Channel based Market, 2021 - 2033 (USD Million)
- 4.5.1.2.1.1.2. Direct to consumer
- 4.5.1.2.1.1.2.1. Direct to consumer-based Market, 2021 - 2033 (USD Million)
- 4.5.1.2.1.1.3. Other e-commerce channels
- 4.5.1.2.1.1.3.1. Other e-commerce channels-based Market, 2021 - 2033 (USD Million)
- 4.5.1.2.1.2. Offline
- 4.5.1.2.1.2.1. Offline Sales Channel based Market, 2021 - 2033 (USD Million)
- 4.5.1.2.1.2.2. Hypermarkets/Supermarkets
- 4.5.1.2.1.2.2.1. Hypermarkets/Supermarkets-based Market, 2021 - 2033 (USD Million)
- 4.5.1.2.1.2.3. Pharmacies & Drug Stores
- 4.5.1.2.1.2.3.1. Pharmacies & Drug Stores-based Market, 2021 - 2033 (USD Million)
- 4.5.1.2.1.2.4. Others
- 4.5.1.2.1.2.4.1. Others based Market, 2021 - 2033 (USD Million)
- Chapter 5. Competitive Landscape
- 5.1. Company Categorization
- 5.2. Strategy Mapping
- 5.3. Company Market Position Analysis, 2025
- 5.4. Company Profiles/Listing
- 5.4.1. NOW Foods
- 5.4.1.1. Overview
- 5.4.1.2. Financial Performance
- 5.4.1.3. Product Benchmarking
- 5.4.1.4. Strategic Initiatives
- 5.4.2. Life Extension
- 5.4.2.1. Overview
- 5.4.2.2. Financial Performance
- 5.4.2.3. Product Benchmarking
- 5.4.2.4. Strategic Initiatives
- 5.4.3. Nature’s Bounty
- 5.4.3.1. Overview
- 5.4.3.2. Financial Performance
- 5.4.3.3. Product Benchmarking
- 5.4.3.4. Strategic Initiatives
- 5.4.4. Jarrow Formulas
- 5.4.4.1. Overview
- 5.4.4.2. Financial Performance
- 5.4.4.3. Product Benchmarking
- 5.4.4.4. Strategic Initiatives
- 5.4.5. Nature’s Way
- 5.4.5.1. Overview
- 5.4.5.2. Financial Performance
- 5.4.5.3. Product Benchmarking
- 5.4.5.4. Strategic Initiatives
- 5.4.6. Thorne
- 5.4.6.1. Overview
- 5.4.6.2. Financial Performance
- 5.4.6.3. Product Benchmarking
- 5.4.6.4. Strategic Initiatives
- 5.4.7. Himalaya
- 5.4.7.1. Overview
- 5.4.7.2. Financial Performance
- 5.4.7.3. Product Benchmarking
- 5.4.7.4. Strategic Initiatives
- 5.4.8. Pure Encapsulations
- 5.4.8.1. Overview
- 5.4.8.2. Financial Performance
- 5.4.8.3. Product Benchmarking
- 5.4.8.4. Strategic Initiatives
- 5.4.9. Hims & Hers Health, Inc.
- 5.4.9.1. Overview
- 5.4.9.2. Financial Performance
- 5.4.9.3. Product Benchmarking
- 5.4.9.4. Strategic Initiatives
- 5.4.10. Ro
- 5.4.10.1. Overview
- 5.4.10.2. Financial Performance
- 5.4.10.3. Product Benchmarking
- 5.4.10.4. Strategic Initiatives
- 5.4.11. Elysium Health
- 5.4.11.1. Overview
- 5.4.11.2. Financial Performance
- 5.4.11.3. Product Benchmarking
- 5.4.11.4. Strategic Initiatives
- 5.4.12. Niagen Bioscience (ChromaDex)
- 5.4.12.1. Overview
- 5.4.12.2. Financial Performance
- 5.4.12.3. Product Benchmarking
- 5.4.12.4. Strategic Initiatives
- 5.4.13. ProHealth
- 5.4.13.1. Overview
- 5.4.13.2. Financial Performance
- 5.4.13.3. Product Benchmarking
- 5.4.13.4. Strategic Initiatives
- 5.4.14. RevGenetics
- 5.4.14.1. Overview
- 5.4.14.2. Financial Performance
- 5.4.14.3. Product Benchmarking
- 5.4.14.4. Strategic Initiatives
- 5.4.15. Codeage LLC
- 5.4.15.1. Overview
- 5.4.15.2. Financial Performance
- 5.4.15.3. Product Benchmarking
- 5.4.15.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


